ABSTRACT: A rapid, economic and sensitive chemiluminescent method involving flow-injection analysis was developed for the determination of dipyrone in pharmaceutical preparations. The method is based on the chemiluminescent reaction between quinolinic hydrazide and hydrogen peroxide in a strongly alkaline médium, in which vanadium(IV) acts as a catalyst. Principal chemical and physical variables involved in the flow-injection system were optimized using a modified simplex method. The variations in the quantum yield observed when dipyrone was present in the reaction médium were used to determine the concentration of this compound. The proposed method requires no preconcentration steps and reliably quantifies dipyrone over the linear range 1-50ug/mL. In addition, a sample throughput of 85 samples/h is possible.
Introduction
Dipyrone, also known as metamizol, methanesulphonic acid or analgin, is a drug of the pyrazolone (phenylpyrazolone) family with analgesic, antipyretic and anti-inflammatory effects. The pyrazolones have been widely used in medicine, and dipyrone, which was first synthesized in 1920, is now the group's main representative (1) . Sodium dipyrone (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1/-/-pyrazol-4-yl-methylamino-methanesulphonate) is one of its most used salts, since it is soluble in water and is an effective non-opioid analgesic for treating acute pain. The data available on the clinical efficacy of single dose dipyrone in postoperative pain management have been analysed by the Cochrane Collaboration (2) . Compared to a placebo, dipyrone showed an NNT valué (i.e. the number needed to treat for pain relief of at least 50% for 4-6 h in patients with modérate to severe pain) of 2.5 for 500 mg and 1.9 for 1 g. Intramuscularlyinjected dipyrone (2g) has been reported to show a greater analgesic effect than lOOmg pethidine, 30 mg ketorolac or 10 mg morphine. In addition, oral doses of 500 mg and 1g dipyrone are reported to be more effective than 400 mg ibuprofen, 600 mg aspirin or 1 g paracetamol (3).
Like many substances, dipyrone has been associated with side-effects, in this case agranulocytosis and anaphylactic shock reactions (4) (5) (6) . Its use remains popular in some parts of Europe, the Middle East, Asia, África and Latin America, but in others it is not registered, and in the UK, Sweden and the USA its use is forbidden (2, 3) . Some research on dipyrone has shown, however, that the risks of agranulocytosis are minimal (7), and shock reactions are common to all antipyretic analgesics. Further, the available evidence suggests that its use is associated with no gastric or renal side-effects -common problems of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) (8) . Indeed, the risk of agranulocytosis should be understood in the context of the risks associated with the use of other analgesics. Andrade ef al. (9) report the estimated excess mortality due to severe side-effects of aspirin to be 185/100 million and 592/100 million for diclofenac, but only 20/100 million for paracetamol and 25/100 million for dipyrone.
Most of the methods used for the determination of this drug are based on titrimetry (10, 11) , amperometry (12) (13) (14) (15) routinely used in pharmaceutical analysis. However, the concentration range that the method of (30) is capable of measuring is reduced (2.5-12.5 ng/mL), that of (29) requires preconcentration procedures be performed, and the throughput of (28) (60/h) could be improved.
In previous work (31) our group reported that, under certain conditions, cyclic hydrazides such as cinchomeronic hydrazide (31,33) and quinolinic hydrazide (34, 35) undergo chemiluminescent reactions that can be used for the determination of compounds such as vanadium and H 2 0 2 . The present work describes a method for dipyrone determination involving the quinolinic hydrazide-H 2 0 2 -vanadium(IV) system. The proposed method is based on the reduction, caused by dipyrone, in the quantum yield of the vanadium(IV)-catalysed quinolinic hydrazide chemiluminescent reaction W max = 420nm). The most important reaction conditions and FIA variables of the reaction were optimized using a super-modified simplex method (32) . The simplicity and selectivity of the proposed method allows the determination of dipyrone concentrations in pharmaceutical preparations without the need for prior separation or preconcentration processes. It also uses relatively inexpensive equipment and has a high sample throughput (85 samples/h).
Experimental Chemicals and reagents
Quinolinic hydrazide (QH; 5,8-dione-6,7-dihydro-pyrido(2,3Ó)pyridazine) is a cyclical hydrazide with a structure similar to luminol; that used in the present work was synthesized in our laboratory following the procedure described by Toro et al. (36) . Briefly, quinolinic acid, hydrazine and water were mixed and heated under reflux for 2h. The characterized by infra-red spectrometry, which confirmed them to be the desired hydrazide (74% purity).
A quinolinic hydrazide stock solution of 2.0 x 10" 2 mol/L was prepared by dissolving 0.82 g of these crystals in 10mL 1 mol/L NaOH (Merck, Spain) and then diluting to 250 ml_ with deionized water. A vanadium(IV) stock solution of 1.0x10" 2 mol/L was prepared from 2.53 g vanadyl sulphate (Merck, Spain) by dilution with 10 mL 0.1 mol/L H 2 S0 4 (Panreac, Spain) and diluting to lOOmL with deionized water and adjusting to pH 1.9. Hydrogen peroxide solutions of 0.25 mol/L were prepared daily by dilution of 2.84mL 30% H 2 0 2 (Foret, Spain; final volume lOOmL) with deionized water.
A 300mg/L dipyrone stock solution ( Fig. 1 ) was prepared by dissolving 150mg of C 13 H 16 N3Na04SH 2 0 (Sigma-Aldrich, Germany) in 500 mL deionized water and adjusting to pH 1.9 with 0.1 mol/L H 2 S0 4 . This stock solution was maintained under refrigeration at 5°C. Working standards within the 0.005 and 200 mg/L dipyrone range were prepared daily by water dilution of the above stock.
The pharmaceutical formulations of dipyrone analysed were those commercially available in Spain: Nolotil capsules (575 mg), injectable Nolotil (2g/5mL) and injectable Metamizol Normon (2g/5mL). For the analysis of the capsules, the material from 10 capsules was removed, weighed and finely powdered. A sample equivalent to the contents of two capsules was homogenized and dissolved in 60 mL water and filtered (0.45 um). The residue was washed three times with 10 mL water. The pH of the resulting solution was adjusted to 1.9 with 0.1 mol/L H 2 S0 4 before diluting to lOOmL with deionized water. For the analysis of the injectable Nolotil and Metamizol Normon formulations, five samples from single boxes were separately mixed. An aliquot of the mixture equivalent to the contents of one vial (2mL) was diluted to lOOmL with deionized water and adjusted to pH 1.9 with 0.1 mol/L H 2 S0 4 . All the reagents used, with the exception of the quinolinic hydrazide, were of analytical grade. Deionized water was prepared using a Milli-Q system (Millipore).
Apparatus
A Perkin-Elmer LS-50 B spectrofluorimeter equipped with a Labsphere (FSA-PE-50L) luminescence accessory (an integrating sphere that detects emissions from chemiluminescent reactions) was used to measure the light signáis produced in reactions. 
Quantum yield of the system and dipyrone estimation
To study the quantum yield of the HQ-H 2 0 2 -vanadium(IV) [V(IV)] system ¡n the absence of dipyrone, sample solutions of V(IV) (in the range 2x10~3-1 ug/mL) were prepared by serial dilution of the stock solution. All solutions were adjusted to the optimum working pH of 1.9. Samples (1.5mL) were introduced into the chemiluminescence cell though an ¡njection valve and in an aqueous carrier solution (distilled water at pH 1.9; flow rate, 4.5 mL/min).
A solution of quinolinic hydrazide was prepared at 2x10~3 mol/L by dilution of the stock solution. Hydrogen peroxide (1.7x 10~3 mol/L) was pH-adjusted to 13.2 with 0.17 mol/L NaOH. The quinolinic hydrazide-H 2 0 2 solution was pumped at a flow rate of 4.5 mL/min and mixed at the junction of the T-piece, with the carrier solution also flowing at a rate of 4.5 mL/min. The mixture was allowed to immediately enter the reaction coil. Chemiluminescent emissions were then recorded by the detection system. All solutions were tested in triplícate.
For the determination of dipyrone, sample solutions were prepared by adding the compound to the V(IV) solution. The dipyrone concentration varied in the range 5x10~3-1 ug/mL; the final V(IV) concentration in all dipyrone solutions was 3.29x10~3 mol/L. Light emissions were then recorded again.
The HPLC comparison determinations were undertaken using methanol and water (65:35, v/v) as mobile phases A and B. The flow rate was 0.6 mL/min. Under these conditions, the retention time of dipyrone was 3.25 min.
System optimization
In this study the systematic super-modrfied simplex multivariate method was used, which varies all the parameters to find the shortest path to the optimum. It is generally recommended in the simplex that the number of variables does not exceed five or six, so as not to créate a very complex system. Initially, experiments were conducted to control the temperature, the presence of oxygen and buffer addition. Because these variables had no signrñcant influence, they were removed from the Simplex system. There was a univariate optimization of ¡njection volume, photomultiplier voltage and concentration of hydrazide and a simplex multivariate optimization of the five main variables: the concentration and pH of the vanadium solution, the pH of the quinolinic hydrazide solution, the H 2 0 2 concentration and the carrier flow rate, making a total of 135 experiments in this part.
Five main system variables were optimized using the super-modrñed simplex method (32) ( system, providing the shortest route to the optimal conditions. This is more efficient and accurate than univariate optimization methods. The latter are more simple to perform and are probably the most widely used in chemistry, but univariate methods suffer from strong interactions between variables, increasing the probability of a false optimum being returned (indeed, this is quite common). The loop volume of the ¡njection valve (1.5mL) and the voltage of the photomultiplier (830 V) were previously optimized and therefore were not included among these variables. The ¡njection volume that provided the highest quantum yield of the system was determined by injecting different times at a constant flow rate. The ranges of the above five variables were optimized by taking into account the data obtained in previous quinolinic hydrazide chemiluminescence studies (34, 35) , in which FIA techniques were not used. The fixed variables were: quinolinic hydrazide concentration, 2.0 x10~3 mol/L; vanadium ¡njection volume, 1.5 mL; and photomultiplier voltage, 830V.
For quinolinic hydrazide solution pH values>13.0, the alkaline function (HJ was used (37) (expressed as NaOH concentration). Table 2 shows the variation in chemiluminescence intensity with pH. These results confirm that the reaction is dependent on pH and that a strongly alkaline médium is required for the best results. Figure 3 shows the vanadium(IV)-catalysed mechanism of reaction between quinolinic hydrazide and H 2 0 2 . Dipyrone reduces the quantum yield by interfering with reaction (A), i.e. the formation of the semidione radical. This radical is an intermedíate compound in the formation of excited phthalate ions, those responsible for light emissions.
Results and discussion

Analytical performance and validation
The calibration curve for dipyrone determination showed a linear interval between 1 and 50ug/mL The experimental data fitted a straight line, obtained by the least squares method, with a correlation coefficient of /? = 0.998 for n = 7. The equation of this line was: / = 879.24 (± 6.67) -5.73 (± 0.29) C, where / is the relative intensity of the emission and C is the dipyrone concentration in ug/mL The detection limit, calculated by the method of Miller (38) , was 2.52ug/ml_ for a signahnoise (S:N) ratio of 3. The quantitation limit (S:N = 10) was 8.4ug/ml_. The relative standard deviation (RSD) for seven dipyrone injections (15 ug/mL) was 3%. Eighty-five samples can be processed in 1 h.
Application of the method
For the injectable formulations, the results and recoveries were in good agreement with those provided by the HPLC reference procedure. No significant differences in dipyrone concentration were seen between the proposed method and HPLC at the 95% confidence level (4x P <^tab)/ comparing variances by the procedure described by Miller (38) (Table 3 ). However, for the solid formulations the results were not very good, probably due to the excipients present. In the Nolotil capsules, magnesium stearate is a major excipient. índigo carmine, erythrosine, titanium dioxide and gelatin are also present in lesser amounts (Table 4) .
Compared to the current chemiluminescent/FIA procedures for dipyrone estimation (28-30), the proposed method offers certain advantages: (a) the range of dipyrone concentrations that can be detected is greater than that offered by the (30) method; (b) there is no need for preconcentration, as in the (29) method; and (c) the throughput is greater than that of the (28) method (85 samples/h compared to 60/h). Table 5 compares the characteristics of the proposed method with those of the above and several other methods for determining dipyrone (15, 20, 24, 25, (28) (29) (30) .
Conclusión
This new method for determining dipyrone concentrations in injectable pharmaceutical preparations provides results comparable to those obtained using an HPLC reference techniquebut more quickly and cheaply. It also provides advantages over 
